In the 3rd year of the SARS-CoV-2 pandemic, much has been learned about the long-term
effects of COVID-19 pneumonia on the lungs. Approximately one-third of patients with …

As of this writing, it is estimated that there have been nearly 600 million cases of coronavirus
disease 2019 (COVID-19) around the world with over six million deaths. While shocking …

Wealthy nations must step up support for Africa and vulnerable countries in addressing past,
present, and future impacts of climate change. The 2022 report of the Intergovernmental …

Clinical sequelae and symptoms for a considerable number of COVID-19 patients can linger
for months beyond the acute stage of SARS-CoV-2 infection,“long COVID”. Among the long …

Background: A post-COVID condition can reduce activity and quality of life, resulting in a
significant socioeconomic and health burden. Understanding its impact on patients' health is …

Long coronavirus disease 19 (COVID-19) is the designation given to a novel syndrome that
develops within a few months after infection by severe acute respiratory syndrome …

The coronavirus 2019 (COVID-19) disease has long-term effects, known as post-COVID
conditions (PCC) or long-COVID. Post-COVID-19 syndrome is defined by signs and …

Neuromuscular symptoms may develop or persist after resolution of severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) infection. Besides residual sensorimotor symptoms …

Symptom-based disorders are conditions that are characterised mostly by somatic
symptoms rather than objectively identifiable signs. They are very common, including pain …

Objectives To determine association of biomarkers—high-sensitivity C reactive protein
(hsCRP), D-dimer, interleukin-6 (IL-6), lactic dehydrogenase (LDH), ferritin and neutrophil …